Orthopedics and Spine
FDA Approves Abbott’s “Low Dose,” Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life
Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company’s Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform offers a low dose of Abbott’s proprietary BurstDR™ stimulation waveform, which was...